ACM Research's China Dependence Meets Its First Real Test Outside the Mainland
ACM Research (NASDAQ: ACMR) reports second-quarter 2026 earnings before market open on August 7, 2026, with analysts expecting a sharp sequential decline in profitability. The central question is whether the semiconductor equipment maker can sustain momentum from its exceptional first-quarter surprise or if the business is entering a period of normalization. With the stock trading well above its 200-day moving average but below key shorter-term levels, technical positioning suggests investors are cautiously optimistic heading into the print.
Part 1: Earnings Preview
ACM Research develops, manufactures, and sells advanced semiconductor process equipment for cleaning, etching, and other critical manufacturing steps, serving customers primarily in China and other Asian markets. The company has carved out a niche in wet cleaning and other front-end semiconductor manufacturing processes, positioning itself as a key supplier to the rapidly growing Chinese semiconductor industry.
ACMR is scheduled to report Q2 2026 results before market open on August 7, 2026. The consensus estimate calls for EPS of $0.21, with revenue expected around $274.66 million. The company most recently reported Q1 2026 EPS of $0.26, which dramatically exceeded expectations. Compared to the year-ago quarter (Q2 2025), when ACMR earned $0.40 per share, the current estimate implies a 47.5% year-over-year decline — a significant deceleration that has investors questioning whether the first quarter represented a peak.
Three key themes define this earnings story:
China Semiconductor Demand Trajectory: ACMR's fortunes are closely tied to Chinese semiconductor fab investment, which has shown volatility amid geopolitical tensions and export restrictions. Investors will scrutinize order flow and guidance for signs that domestic Chinese demand remains robust enough to offset any slowdown in international markets.
Margin Sustainability: The sharp sequential decline in EPS estimates suggests concerns about either revenue mix, pricing pressure, or operating leverage. With Q1 delivering a massive earnings surprise, the question is whether margins can hold or if that quarter represented unusually favorable conditions.
Full-Year Trajectory: Current full-year 2026 estimates sit at $1.02 per share, down from prior expectations of $1.11, while 2027 estimates project a strong rebound to $1.54 (up 50.98%). The Q2 print will be critical in determining whether the company is on track for this recovery narrative or if estimates need further adjustment.
Analyst commentary ahead of the release has been limited given the single-analyst coverage reflected in recent estimates, but the broader analyst community of 10 firms maintains a strongly bullish stance with 8 Strong Buy ratings and a mean price target of $102.14, suggesting confidence in the longer-term growth story despite near-term estimate volatility.
Part 2: Historical Earnings Performance
ACM Research has demonstrated extreme volatility in earnings execution over the past year, with surprises ranging from massive beats to significant misses. The most recent quarter (Q1 2026) delivered a +550.00% surprise, reporting $0.26 against a consensus of just $0.04 — an extraordinary outperformance that suggests either severely conservative estimates or an unexpectedly strong business environment. This followed two consecutive disappointing quarters: Q4 2025 missed by 42.31% and Q3 2025 missed by 21.87%.
Looking back further, the pattern shows inconsistency rather than a clear trend. Q2 2025 delivered a strong +53.85% beat, but the subsequent two quarters disappointed before the dramatic Q1 2026 reversal. This volatility likely reflects the lumpy nature of semiconductor equipment orders, where large customer purchases can significantly impact quarterly results, as well as potential challenges in forecasting demand in the rapidly evolving Chinese semiconductor market.
The wide swings in both directions suggest analysts have struggled to model ACMR's business accurately, making the upcoming Q2 print particularly difficult to handicap. The sharp downward revision in Q2 estimates (from $0.40 prior to $0.21 current) indicates analysts are taking a more conservative stance after the Q1 surprise, possibly expecting a return to more normalized business conditions.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $0.26 | $0.40 | +53.85% | Beat |
| Sep 2025 | $0.32 | $0.25 | -21.87% | Miss |
| Dec 2025 | $0.26 | $0.15 | -42.31% | Miss |
| Mar 2026 | $0.04 | $0.26 | +550.00% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
ACM Research typically reports earnings before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-07 | +$3.82 (+6.90%) | $11.45 (20.68%) | +$0.65 (+1.10%) | $4.32 (7.30%) |
| 2026-02-26 | -$11.43 (-16.69%) | $11.16 (16.30%) | -$1.36 (-2.38%) | $3.41 (5.98%) |
| 2025-11-05 | -$7.76 (-19.95%) | $2.84 (7.30%) | -$0.22 (-0.71%) | $1.83 (5.89%) |
| 2025-08-06 | -$4.55 (-15.35%) | $2.74 (9.24%) | -$0.83 (-3.31%) | $1.82 (7.26%) |
| 2025-05-08 | +$2.40 (+11.98%) | $3.15 (15.75%) | -$0.24 (-1.07%) | $1.55 (6.90%) |
| 2025-02-26 | +$4.75 (+20.71%) | $2.09 (9.11%) | -$1.59 (-5.74%) | $2.46 (8.88%) |
| 2024-11-07 | +$1.65 (+8.71%) | $2.42 (12.77%) | -$1.38 (-6.70%) | $1.52 (7.39%) |
| 2024-08-07 | +$2.46 (+16.30%) | $2.03 (13.42%) | +$1.90 (+10.80%) | $1.65 (9.38%) |
| Avg Abs Move | 14.57% | 13.07% | 3.98% | 7.37% |
Historical price behavior shows ACMR is a highly volatile earnings stock, with an average absolute Day 0 move of 14.57% — substantially higher than typical market reactions. The most recent earnings (May 2026) produced a 6.90% gain on Day 0 following the massive earnings beat, with relatively modest follow-through of 1.10% on Day +1. However, the prior three reports all generated significant Day 0 declines: -16.69% (February 2026), -19.95% (November 2025), and -15.35% (August 2025), demonstrating the stock's sensitivity to disappointment.
The Day 0 trading range averages 13.07%, indicating substantial intraday volatility as investors digest results and guidance. Day +1 moves average 3.98% with a 7.37% range, suggesting continued volatility into the second session. Notably, several recent earnings saw significant Day +1 reversals, including a -5.74% decline following the February 2026 beat and a +10.80% surge after August 2024 results, indicating that initial reactions don't always hold.
Investors should prepare for a potentially dramatic move in either direction, with historical precedent suggesting double-digit percentage swings are common for ACMR around earnings events.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/07/26 (DTE 1) |
| Expected Move | $8.50 (10.76%) |
| Expected Range | $70.50 to $87.50 |
| Implied Volatility | 284.33% |
The options market is pricing an expected move of 10.76% (±$8.50) for this earnings event, which is notably lower than the stock's average historical Day 0 move of 14.57%. This suggests options traders may be underpricing potential volatility, particularly given ACMR's track record of exceeding 15% moves in four of the past eight earnings reports. The discrepancy could present opportunity for volatility traders or warrant extra caution for equity holders, as history suggests the actual move could exceed what options are pricing in.
Part 3: What Analysts Are Saying
Analyst sentiment on ACM Research remains decidedly bullish despite recent estimate volatility. The consensus rating stands at 4.60 out of 5.0, with 8 Strong Buy ratings, 0 Moderate Buys, 2 Holds, and no Sell ratings among the 10 analysts covering the stock. This represents an unchanged sentiment trend over the past month, indicating analysts have maintained conviction even as near-term estimates have been reduced.
The average price target of $102.14 implies approximately 29% upside from the current price of $78.98, suggesting analysts see the recent pullback as a buying opportunity rather than a reflection of deteriorating fundamentals. The range of targets is wide, spanning from a low of $70.00 to a high of $164.00, reflecting differing views on the company's growth trajectory and ability to capitalize on Chinese semiconductor market expansion.
The fact that sentiment has held steady despite the sharp reduction in Q2 estimates (from $0.40 to $0.21) suggests analysts view the near-term softness as temporary rather than structural. The strong 2027 growth estimate of +50.98% indicates the analyst community expects a significant reacceleration in profitability, likely driven by anticipated recovery in semiconductor equipment demand and ACMR's expanding market share in China. The concentration of Strong Buy ratings reflects confidence that the long-term growth story remains intact despite quarterly volatility.
Part 4: Technical Picture
The Barchart Technical Opinion currently shows a Buy signal at 40%, down from 80% one month ago, indicating a significant deterioration in technical momentum heading into earnings. The signal has held at 40% for the past week, suggesting the recent weakness has stabilized but not yet reversed.
Timeframe Analysis:
- Short-term (Hold): Neutral reading indicates near-term momentum has stalled after the recent decline from higher levels
- Medium-term (50% Buy): Moderate buy signal suggests the intermediate trend remains constructive despite recent weakness
- Long-term (100% Buy): Strong buy signal reflects the stock's substantial gains over the longer timeframe, with price well above the 200-day moving average
Trend Characteristics: The combination of Average strength and Weakest direction suggests ACMR is in a consolidation phase within an established uptrend, with momentum fading but the overall trend structure still intact.
The stock currently trades at $78.98, positioned above both the 10-day moving average ($77.88) and the longer-term 100-day ($72.13) and 200-day ($58.93) averages, confirming the longer-term uptrend remains valid. However, price has fallen below the 5-day ($79.70), 20-day ($84.52), and 50-day ($91.62) moving averages, indicating recent weakness and a loss of shorter-term momentum.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $79.70 | 50-Day MA | $91.62 |
| 10-Day MA | $77.88 | 100-Day MA | $72.13 |
| 20-Day MA | $84.52 | 200-Day MA | $58.93 |
The technical setup heading into earnings is mixed, with the stock caught between longer-term support and shorter-term resistance. The decline from the 50-day moving average at $91.62 to current levels represents a 13.8% pullback, bringing ACMR into a potential value zone for bulls while also raising concerns about deteriorating momentum. The 10-day moving average at $77.88 represents immediate support, while the 20-day at $84.52 marks the first significant resistance level. Given the stock's tendency for double-digit earnings moves and the current technical positioning below key short-term averages, the setup appears cautionary — a disappointing print could trigger further technical breakdown toward the 100-day average, while a strong beat would need to reclaim the 20-day and 50-day averages to confirm a resumption of the uptrend. The weakening technical momentum suggests the market is positioning defensively ahead of results.